Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas

BackgroundWnt inhibitory factor-1(WIF-1) acts as a Wnt-antagonists and tumor suppressor, but hypermethylation of WIF-1 gene promoter and low expression activate Wnt signaling aberrantly and induce the development of various human tumors. With this work we intended to investigate the expression and promoter methylation status of WIF-1 gene in human astrocytomas.MethodsThe tissue samples consisted of 53 astrocytomas and 6 normal brain tissues. The expression levels of WIF-1 were determined by immunohistochemistry and semiquantitative RT-PCR. The results were analyzed in correlation with clinicopathological data. Methylation status of WIF-1 gene promoter was investigated using methylation specific PCR. The relationship between methylation and expression of the genes was analyzed.ResultsThe average expression levels of WIF-1 protein and mRNA in astrocytomas were decreased significantly compared with normal control tissues. The protein and mRNA expression of WIF-1 gene in astrocytomas was decreased with the increase of pathological grade. Furthermore, WIF-1 promoter methylation was observed by MS-PCR in astrocytomas which showed significant reduction of WIF-1 expression. The WIF-1 promoter hypermethylation was associated with reduced expression of WIF-1 expression.ConclusionOur results demonstrate that the WIF-1 gene is frequently down-regulated or silenced in astrocytomas by aberrant promoter methylation. This may be an important mechanism in astrocytoma carcinogenesis.

• Publication year

  2010

• Venue

  Journal of experimental & clinical cancer research : CR

• Publication date

  2010-03-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/1756-9966-29-26PMID 20334650PMCID 2851677
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ectopic endometrium in human foetuses is a common event and sustains the theory of müllerianosis in the pathogenesis of endometriosis, a disease that predisposes to cancer

  2009cited by this paper
• Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.

  2009cited by this paper
• Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth

  2009cited by this paper
• p15 promoter methylation - a novel prognostic marker in glioblastoma patients.

  2009cited by this paper
• Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma.

  2009cited by this paper
• Wnt/β-catenin/Tcf Signaling Pathway Activation in Malignant Progression of Rat Gliomas Induced by Transplacental N-Ethyl-N-Nitrosourea Exposure

  2009cited by this paper
• Aberrant methylation and reduced expression of LHX9 in malignant gliomas of childhood.

  2009cited by this paper
• Malignant gliomas in adults.

  2008cited by this paper
• Expression pattern of Wnt inhibitor factor 1(Wif1) during the development in mouse CNS.

  2008cited by this paper
• Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma.

  2007cited by this paper
• Role of Wnt5a in the proliferation of human glioblastoma cells.

  2007cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Wnt Signaling Pathway in Mammary Gland Development and Carcinogenesis

  2007cited by this paper
• Wnt/beta-catenin signaling in cancer stemness and malignant behavior.

  2007cited by this paper
• Wnt/β-catenin signaling in cancer stemness and malignant behavior

  2007cited by this paper
• Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines.

  2006cited by this paper
• Epigenetic Inactivation of Wnt Inhibitory Factor-1 Plays an Important Role in Bladder Cancer through Aberrant Canonical Wnt/β-Catenin Signaling Pathway

  2006cited by this paper
• Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers

  2005cited by this paper
• Correlation of Clinical Features and Methylation Status of MGMT Gene Promoter in Glioblastomas

  2004cited by this paper
• Cloning and characterization of the promoter of human Wnt inhibitory factor-1.

  2004cited by this paper
• Wnt Inhibitory Factor-1 Is Silenced by Promoter Hypermethylation in Human Lung Cancer

  2004cited by this paper
• Secreted antagonists of the Wnt signalling pathway

  2003cited by this paper
• WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer

  2003cited by this paper
• The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.

  2003cited by this paper
• Gene silencing in cancer in association with promoter hypermethylation.

  2003cited by this paper
• The fundamental role of epigenetic events in cancer

  2002cited by this paper
• Behavioural genetics: Worms gang up on bacteria

  2002cited by this paper
• Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398.

  2000cited by this paper
• A new secreted protein that binds to Wnt proteins and inhibits their activites

  1999cited by this paper
• Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.

  1999cited by this paper
• Identification of c-MYC as a target of the APC pathway.

  1998cited by this paper
• Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours.

  1997cited by this paper

• Histological grade 2 and non-contrast-enhancing phenotype provide prognostic information complementary to DNA methylation classification in TERTp-mutant molecular glioblastomas.

  2026cites this paper
• Gene Expression Patterns Associated with Survival in Glioblastoma

  2024cites this paper
• Aberrant promoter methylation of Wnt inhibitory factor-1 gene is a potential target for treating psoriasis.

  2023cites this paper
• The effect of ω-6 fatty acid on WT1 and WIF-1 genes expression and inducing apoptosis in A375 melanoma cell line

  2022cites this paper
• TROAP regulates cell cycle and promotes tumor progression through Wnt/β‐Catenin signaling pathway in glioma cells

  2021cites this paper
• UAP1L1 plays an oncogene-like role in glioma through promoting proliferation and inhibiting apoptosis

  2021cites this paper
• Frizzled 1 and Wnt1 as new potential therapeutic targets in the traumatically injured spinal cord

  2020cites this paper
• The clinical significance of VDR and WIFI downregulation in colorectal cancer tissue

  2020cites this paper
• Promoter Hypermethylation of Wnt/β-catenin Signaling Pathway Inhibitor WIF-1 Gene and its Association with MTHFR C677T Polymorphism in Patients with Colorectal Cancer

  2020cites this paper
• Berberine inhibits cell growth via Wnt / beta-catenin signaling in glioma

  2019cites this paper
• Regulation of Oxidative Stress by Nitric Oxide Defines Lung Development and Diseases

  2019cites this paper
• OTT_A_206142 10841..10850

  2019cites this paper
• Biological Functions of TNKS1 and Its Relationship with Wnt/β-Catenin Pathway in Astrocytoma

  2019cites this paper
• SIRT5 downregulation is associated with poor prognosis in glioblastoma

  2019cites this paper
• Association of TGF-β1 and WIF1 Expression with 36 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas: A High-Throughput Tissue Microarrays Immunohistochemical Study.

  2018cites this paper
• Tcf Signaling Pathway

  2018cites this paper
• The Effects of Omega-3 PUFA (ALA) on WT1 Gene Expression in Pancreatic Cancer Cell Line (MIA PaCa-2)

  2018cites this paper
• DNA methylation patterns as molecular biomarkers: an overview in colorectal cancer

  2018cites this paper
• Aberrant Wnt signaling: a special focus in CNS diseases

  2017cites this paper
• SFRP 5 as a prognostic biomarker for patients with pancreatic ductal adenocarcinoma

  2016cites this paper
• Cross-Species Analysis of Gene Expression and Function in Prefrontal Cortex, Hippocampus and Striatum

  2016cites this paper
• Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma.

  2016cites this paper
• Association between Wnt inhibitory factor-1 expression levels in articular cartilage and the disease severity of patients with osteoarthritis of the knee.

  2016cites this paper
• Native Oligodendrocytes in Astrocytomas Might Inhibit Tumor Proliferation by WIF1 Expression

  2016cites this paper
• Genetics of Cerebellar Low-Grade Astrocytomas

  2015cites this paper
• Coexpression of SFRP 1 and WIF 1 as a Prognostic Predictor of Favorable Outcomes in Patients with Colorectal Carcinoma

  2015cites this paper
• Norcantharidin inhibits Wnt signal pathway via promoter demethylation of WIF-1 in human non-small cell lung cancer

  2015cites this paper
• Secreted frizzled related proteins: Implications in cancers.

  2014cites this paper
• Coexpression of SFRP1 and WIF1 as a Prognostic Predictor of Favorable Outcomes in Patients with Colorectal Carcinoma

  2014cites this paper
• Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk.

  2013cites this paper
• Promoter methylation of WNT inhibitory factor-1 and expression pattern of WNT/β-catenin pathway in human astrocytoma: pathologic and prognostic correlations

  2013cites this paper
• Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer

  2013cites this paper
• Expression of TNKS1 is correlated with pathologic grade and Wnt/β-catenin pathway in human astrocytomas.

  2012cites this paper
• Deregulation of the Wnt/β-Catenin/Tcf Signaling Pathway in Astrocytomas

  2012cites this paper
• Aberrant DNA methylation of tumor‐related genes in oral rinse

  2012cites this paper
• β-Catenin Signalling in Glioblastoma Multiforme and Glioma-Initiating Cells

  2012cites this paper
• Identification et caractérisation de gènes suppresseurs de tumeurs dans le glioblastome Etudiant

  2011cites this paper
• The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence.

  2011cites this paper
• Dysregulation of the Wnt Pathway in Solid Tumors

  2011cites this paper
• Hypomethylation effects of curcumin, demethoxycurcumin and bisdemethoxycurcumin on WIF-1 promoter in non-small cell lung cancer cell lines.

  2011cites this paper
• Gliomas: Role of Wnt/β-Catenin/Tcf Signaling Pathway

  2011cites this paper
• Targeting the Wnt pathway in cancer

  2011cites this paper
• Researchof candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion

  2010cites this paper
• Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion

  2010cites this paper